Introduction: Non-cystic fibrosis bronchiectasis (NCFB) is considered a chronic heterogenic
pulmonary disease, characterized by the permanent and abnormal enlargement and …

Introduction: Non-cystic fibrosis bronchiectasis (NCFB) is a chronic, progressive, suppurative
lung disease characterized by permanent dilatation of bronchial subdivisions, which further …

Background: The optimum antibiotic therapy for non-cystic fibrosis bronchiectasis (NCFB)
has yet to be determined. A meta-analysis was conducted to evaluate the efficacy and safety …

Abstract Background and Aims The evidence supported the use of nebulized antibiotics in
non‐cystic fibrosis (non‐CF) bronchiectasis is indefinite. A meta‐analysis was performed to …

We conducted a meta-analysis of randomised trials to evaluate the efficacy and safety of
inhaled antibiotics in patients with stable non-cystic fibrosis (CF) bronchiectasis. We …

Objective: To evaluate the efficacy and safety of inhaled antibiotics for the treatment of non-
cystic fibrosis bronchiectasis (NCFB). Methods: Pubmed, Cochrane library, Embase …

Background Inhaled antibiotics (IA) in non-cystic fibrosis bronchiectasis (NCFB) are
recommended by some clinical practice guidelines for prevention or treatment of NCFB …

Introduction: Non-cystic fibrosis bronchiectasis (NCFB) results from a permanent and
progressive destruction of the airways leading to poor lung function. NCFB is characterized …

New therapeutic options for noncystic fibrosis bronchiectasi... : Current Opinion in Infectious
Diseases New therapeutic options for noncystic fibrosis bronchiectasis : Current Opinion in …

Noncystic fibrosis bronchiectasis is a chronic, debilitating lung disease characterized by
cycles of infection, inflammation, and progressive airway structural changes. The associated …